Autopsy report · NCT00626574
Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa
Cause of deathSafety
“This study is terminated as a result of data from a study that showed increased mortality in stroke patients.”
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 3 years 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of South Florida
- Sponsor type
- University, hospital or other
- Conditions
- Subarachnoid Hemorrhage
- Interventions
- Epoetin alfa; Saline
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
“Study terminated due to various reasons impacting the feasibility of future clinical development” - Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty
“The study was terminated prematurely due to the inapplicability of the primary outcome measure” - Adherence to Medical Treatments for Telemedicine Patients
“Study closed due to not able to find any real stroke patients interested to participate.” - Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
“The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)” - Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
“The study was terminated in the interest of patient safety.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.